Skip to content

Frailty Syndrome of Post-cancer Treatment Eldery Patients

Impact of Exercise and Nutritional Support on the Frailty Syndrome of Eldery Patients in Phase of Post-cancer Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04746768
Acronym
PANACEE
Enrollment
100
Registered
2021-02-10
Start date
2021-05-04
Completion date
2024-01-31
Last updated
2021-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Exercise, Frailty Syndrome, Nutritional Support

Brief summary

Decrease the prevalence of frailty syndrome in individuals with complete response of cancer.

Interventions

exercise and nutritional support program during an active support phase (0 to 6 months) followed by an empowerment phase (from 6 to 12 months)

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* in complete remission from cancer (all type of cancer) * have a frailty syndrome (positive GFST score) * ability to provide signed informed consent * be affiliated with social security or beneficiary of such a scheme

Exclusion criteria

* patient with active cancer or any other pathology affecting the prognosis at 5 years * currently participating or having participated in the month preceding inclusion in another interventional clinical research that may impact the study. This impact is left to the investigator discretion * subjects referred to articles L1121-5 to L1121-8 of CSP (corresponds to all protected persons: person deprived of liberty by judicial or administrative decision, person subject to legal protection measure)

Design outcomes

Primary

MeasureTime frameDescription
Change of the prevalence of frailty syndrome in individuals with complete response of cancer0, 6 and 12 monthsevolution of individual frailty during a multimodal intervention (physical and nutritional activity) according to the Fried's criteria

Secondary

MeasureTime frameDescription
evaluation of predicitive variables of frailty syndrome reversionMonth 0, 6 and 12The criterion determining the frail status is the Fried score classified into 3 categories: not frail; pre-frail; frail. A change from frail to pre-frail or to not frail will be considered as an improvement. Measurements of the Frailty score and other markers on nutrition and APA will be carried out at month 0 (basic measurements), then measured at month 6 (end of APA and nutritionist support) and at month12 (6 months after empowerment). All of health markers collected during the basic assessment, changes in parameters (month 6) and compliance with APA and nutrition support (from Month 1 to Month 6 then between Month 6 and Month 12) will be tested as variables potentially predictive of an improvement in the frailty syndrome.
Change from baseline nutritional status during nutritionist support (month 3 and 6) and at the end of empowerment (month 12)Month 0, 3, 6 and 12nutritional parameters measured at each time frame for weight, VAS appetite score, MNA score, nutritional calculation (food survey and self-questionnaire), bio impedancemetry and biomarkers of nutrition (levels of albumin, prealbumin, C reactive protein, CBC, liver and kidney function)
Measure adherence to APA interventions and exercise practicesbetween month 1 to 6 and between month 6 to 12Adherence to APA support program throughout the study will be evaluated by measurements and sum of multiple parameters: number of sessions recorded on the heart rate monitor, average energy expenditure (in kcal) measured by the heart rate monitor,number of sets of exercises performed relative to the number of exercises recommended for muscle strengthening recorded in the patient notebook, CESS scale to assess beliefs about cancer patients and physical activity
Correlations between physical performance and frailty syndrome and their evolutionsMonth 0, 6 and 12measurement of VO2peak + ventilatory thresholds measured in a stress test, muscle strength/endurance (number of chair raises for 30 seconds), walking speed (10-meter walking test, 6-minute walk test), balance (Tinette score), coordination (functional mobility test), cardio-respiratory endurance (heart rate measurement in relation to pedaling power)
Measure the durability of long-term activitiesMonth 6 and 12number of monthly patient connections to heart rate monitor; evaluation of the completion of patient notebook
Measure health related quality of life on mobility, personal autonomy, current activities, pain/discomfort and anxiety/depressionMonth 0, 6 and 12Assessment of quality of life with EQ-5D questionnaire by comparison to the basal state (M0).
Sociological study on motivation: evaluation of the perception and experience of treating patientsMonth 6 and 12a series of qualitative interviews with a panel of 15 patients, during 2 interview sessions: 1 after support phase and 1 at the end of autonomy phase. Interview will collect past/current socio-professional life, socialization in physical activity and nutrition.
Estimation of adherence to nutritional interventionsMonth 6 and 12comparison between active support phase and empowerment phase with food self-questionnaire

Countries

France

Contacts

Primary ContactGaëtan Gavazzi, MD, PhD
ggavazzi@chu-grenoble.fr(0)476765421
Backup ContactStéphane Mouret, PhD
smouret1@chu-grenoble.fr(0)476767081

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026